Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent ovarian cancer: Final results Meeting Abstract

  

Authors:	Grisham, R.; Giri, D.; Henson, M.; Iasonos, A.; Zhou, Q.; McDonnell, A.; Girshman, J.; O'Cearbhaill, R.; Zamarin, D.; Aghajanian, C.
Abstract Title:	Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent ovarian cancer: Final results
Meeting Title:	2019 IGCS Annual Global Meeting
Journal Title:	International Journal of Gynecological Cancer
Volume:	29
Issue:	Suppl. 3
Meeting Dates:	2019 Sep 19-21
Meeting Location:	Rio de Janeiro, Brazil
ISSN:	1048-891X
Publisher:	Lippincott Williams & Wilkins
Date Published:	2019-09-01
Start Page:	A23
Language:	English
ACCESSION:	WOS:000491998200039
DOI:	10.1136/ijgc-2019-IGCS.38
PROVIDER:	wos
Notes:	Meeting Abstract: 38 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/157393